Knight Therapeutics (KHTRF) News Today $4.39 0.00 (0.00%) As of 04/4/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Knight Therapeutics Inc. ranks on The Globe and Mail's sixth-annual Women Lead Here benchmark of executive gender diversityMarch 28, 2025 | investing.comKnight Therapeutics Inc. ranks on The Globe and Mail’s sixth-annual Women Lead Here benchmark of executive gender diversityMarch 28, 2025 | financialpost.comKnight Therapeutics Full Year 2024 Earnings: Beats ExpectationsMarch 26, 2025 | finance.yahoo.comStifel Nicolaus Reaffirms Their Buy Rating on Knight Therapeutics (KHTRF)March 25, 2025 | markets.businessinsider.comKnight Therapeutics’ Earnings Call: Record Revenues Amid ChallengesMarch 22, 2025 | msn.comStifel Nicolaus Remains a Buy on Knight Therapeutics (KHTRF)March 21, 2025 | markets.businessinsider.comKnight Therapeutics (KHTRF) Gets a Buy from RBC CapitalMarch 21, 2025 | markets.businessinsider.comKnight Therapeutics sees FY25 revenue C$390M-C$405MMarch 21, 2025 | markets.businessinsider.comKnight Therapeutics reports FY24 EPS C$0.04 vs. (C$0.16) last yearMarch 21, 2025 | markets.businessinsider.comKnight Therapeutics downgraded to Hold from Buy at CanaccordMarch 21, 2025 | markets.businessinsider.comKnight Therapeutics Inc. (KHTRF) Q4 2024 Earnings Call TranscriptMarch 20, 2025 | seekingalpha.comKnight Therapeutics Reports Fourth Quarter and Year-End 2024 ResultsMarch 20, 2025 | financialpost.comKnight Therapeutics Reports Fourth Quarter and Year-End 2024 ResultsMarch 20, 2025 | globenewswire.comEndo, Inc. to Sell International Pharmaceuticals Business to Knight TherapeuticsMarch 14, 2025 | msn.comKnight Therapeutics (KHTRF) Receives a Buy from Stifel NicolausMarch 13, 2025 | markets.businessinsider.comNotice of Knight Therapeutics’ Fourth Quarter and Year End 2024 Results Conference CallMarch 13, 2025 | financialpost.comNotice of Knight Therapeutics' Fourth Quarter and Year End 2024 Results Conference CallMarch 13, 2025 | globenewswire.comCanaccord Genuity Reaffirms Their Buy Rating on Knight Therapeutics (KHTRF)March 13, 2025 | markets.businessinsider.comKnight Therapeutics to Acquire Paladin Pharma for C$120MMarch 11, 2025 | marketwatch.comKnight Therapeutics to buy Paladin Pharma in bid to build out Canadian businessMarch 11, 2025 | theglobeandmail.comKnight Therapeutics upgraded to Buy from Hold at Mackie Research CapitalMarch 11, 2025 | markets.businessinsider.comKnight Therapeutics to Acquire PaladinMarch 11, 2025 | financialpost.comKnight Therapeutics and Helsinn Healthcare SA Expand Relationship and Enter into Exclusive License, Distribution, and Supply Agreement for Onicit®January 28, 2025 | financialpost.comKnight Therapeutics and Helsinn Healthcare SA Expand Relationship and Enter into Exclusive License, Distribution, and Supply Agreement for Onicit®January 28, 2025 | financialpost.comKnight Therapeutics and Helsinn Healthcare SA Expand Relationship and Enter into Exclusive License, Distribution, and Supply Agreement for Onicit®January 28, 2025 | globenewswire.comKnight Therapeutics Inc. (TSE:GUD) most popular amongst individual investors who own 41% of the shares, institutions hold 24%December 27, 2024 | uk.finance.yahoo.comKnight Therapeutics Announces Regulatory Approval of TAVALISSE® in MexicoDecember 12, 2024 | globenewswire.comKnight Therapeutics price target lowered to C$7.50 from C$8 at Raymond JamesNovember 15, 2024 | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Knight Therapeutics (KHTRF)November 9, 2024 | markets.businessinsider.comKnight Therapeutics Inc. (KHTRF) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comKnight Therapeutics Inc (KHTRF) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Margin ...November 8, 2024 | finance.yahoo.comKnight Therapeutics Reports Third Quarter 2024November 7, 2024 | globenewswire.comNotice of Knight Therapeutics' Third Quarter 2024 Results Conference CallOctober 31, 2024 | globenewswire.comKnight Therapeutics Inc (KHTRF) Q2 2024 Earnings Call Highlights: Record Revenues and Strategic ...October 10, 2024 | finance.yahoo.comKnight Therapeutics Inc. places No. 397 on The Globe and Mail's sixth annual ranking of Canada's Top Growing CompaniesSeptember 27, 2024 | globenewswire.comKnight Therapeutics Reports Second Quarter 2024August 8, 2024 | globenewswire.comNotice of Knight Therapeutics' Second Quarter 2024 Results Conference CallAugust 1, 2024 | globenewswire.comKnight Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 12, 2024 | finance.yahoo.comKnight Therapeutics Up Near 3% After Announcing Supply and Distribution Agreement For ADHD Medication; Despite Mixed Q1May 9, 2024 | finance.yahoo.comKnight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin AmericaMay 9, 2024 | globenewswire.comKnight Therapeutics Reports First Quarter 2024 ResultsMay 9, 2024 | globenewswire.comKnight Therapeutics Inc. announces voting results from the Annual General MeetingMay 8, 2024 | globenewswire.comKnight to Present at the 2024 RBC Capital Markets Global Healthcare Conference in New York CityMay 7, 2024 | finance.yahoo.comNotice of Knight Therapeutics' First Quarter 2024 Results Conference CallMay 2, 2024 | globenewswire.comKnight Therapeutics Inc. ranks on The Globe and Mail’s fifth-annual Women Lead Here benchmark of executive gender diversityMarch 28, 2024 | finance.yahoo.comKnight Therapeutics Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest ForecastsMarch 24, 2024 | finance.yahoo.comKnight Therapeutics Reports Fourth Quarter and Year-End 2023 ResultsMarch 21, 2024 | globenewswire.comKnight Therapeutics Inc.March 14, 2024 | baystreet.caNotice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference CallMarch 14, 2024 | globenewswire.comKnight Therapeutics price target raised by C$0.50 at Raymond JamesMarch 6, 2024 | realmoney.thestreet.com Remove Ads Get Knight Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KHTRF and its competitors with MarketBeat's FREE daily newsletter. Email Address KHTRF Media Mentions By Week KHTRF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KHTRF News Sentiment▼0.000.63▲Average Medical News Sentiment KHTRF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KHTRF Articles This Week▼00▲KHTRF Articles Average Week Remove Ads Get Knight Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KHTRF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FFNTF News ABSCF News ACRHF News LBTSF News AZFL News ERBB News AVTBF News AVCNF News BIOGY News BIOYF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:KHTRF) was last updated on 4/7/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Knight Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KHTRF Stock Free KHTRF Stock Alerts